Research into hospital quality performance typically considers a single dimension of quality at a time (e.g., West et al., 2002; McFadden et al., 2004) . But as both hospitals and payers are aware, quality is multidimensional and needs to be measured more holistically to capture top performers. Data envelopment analysis (DEA) is a useful tool that typically looks at economic or cost data to determine the most efficient organisations in a group (with few exceptions). Using data from cardiology units in a sample of hospitals, this paper presents results from the use of DEA to study multiple quality metrics simultaneously in a geographically clustered group of hospitals to determine the best performers. This type of analysis might be useful for a hospital payer or a government agency that wants to reward hospitals for greater quality performance, but might otherwise be using a single dimension. Even those organisations that use multiple quality measures must face the problem of how to combine these different dimensions into one comprehensive quality measure. Our results highlight the usefulness of this technique in this situation and demonstrate how this technique can identify organisations that might otherwise be overlooked as high performers using traditional, single-dimension methods. 
Introduction
Hospitals are under increasing pressure to improve their performance and a variety of approaches have been used to assess performance in the healthcare management literature. Healthcare costs have become an important issue, so the use of cost improvement or cost containment as a performance measure has been very common in healthcare research (Kumar and Motwani, 1999; Butler et al., 1996) . Quality has also been very widely used as a performance outcome in healthcare research, even as it has often been overlooked in economic analyses of hospitals (Butler et al., 1996; Caron et al., 2004; Chesteen et al., 2005) . Quality has been measured in many different ways, including self-reported quality measures (Butler and Leong, 2000) , medical errors (McFadden et al., 2004) , length of stay (LOS) (Thomas et al., 1997) , and risk-adjusted mortality rates (RAMR) (Caron et al., 2004; Madison, 2004; Gross et al., 2000; MacStravic, 1999) . While RAMR is a widely-used quality measure, it does have its limitations. In-hospital death is a relatively rare event. Thus, RAMRs can only be used to measure quality for a limited number of diagnostic related groups (DRGs). Much of the research in healthcare quality considers only one dimension or considers multiple dimensions but considers them separately and sequentially.
Although each of these single quality measures provides some insight into the quality performance of a hospital, a single measure does not necessarily provide a holistic assessment of a hospital's quality of care. A hospital may excel at one dimension of quality but not others. For example, suppose quality of service is measured by a hospital's LOS, where shorter LOS is taken as an indicator of better quality. However, what if a hospital with a shorter average LOS also had higher complication or mortality rates? We can see from this simple example that considering multiple dimensions can capture potential tradeoffs and provides a better picture of a hospital's quality performance.
The development of such a multidimensional measure of hospital quality performance would be useful in many ways. For example, a payer such as an HMO would have a better indicator of a hospital's quality performance to use in its decision-making process of whether to include the hospital in its network. In addition, a better measure would allow a payer to negotiate reimbursement rates with hospitals on the basis of comparative quality performance, at least in part. In a similar vein, part of US healthcare reform includes the establishment of accountable care organisations (ACOs), which will be rewarded by Medicare based on keeping people healthy, rather than on the traditional fee-for-service system that rewards higher volumes. The current rules for ACOs include many different quality measures (DeVore and Champion, 2011) . ACOs would therefore seem to be one area in which a systematic multidimensional approach to measuring quality would be extremely useful.
If we take the perspective that multiple measures provide a better reflection of quality, then we would also like to consider how multiple measures might be combined into an overall multidimensional measure. Data envelopment analysis (DEA) is a performance and benchmarking tool that incorporates multiple input and output measures simultaneously into a single measure of performance. It has been historically used to measure both technical and allocative efficiency. In DEA, each organisation, or 'decision making unit' (DMU) is evaluated by comparing its multi-dimensional performance with either others in the sample, or with a hypothetical, composite unit that is constructed of a weighted combination of the others in the group. As such, it is capable of comparing efficiencies along multiple dimensions simultaneously. An efficient frontier is created that represents the multidimensional performance of 'best practices' across all possible dimensions. If an organisation is on this frontier, it is deemed 'efficient'. If not, DEA indicates how far an inefficient organisation is from this frontier, and also gives an indication of which other organisations can serve as 'role models' along the various dimensions of performance.
This paper aims to demonstrate the utility of DEA for providing useful insights for organisations seeking to identify a multidimensional quality performance across a population of competing hospitals. As noted above, such analysis might be useful for payers or government agencies aiming to reward or elevate organisations with superior overall outcomes. We use a disguised sample of 29 hospitals in the New York City Metropolitan area to demonstrate the effectiveness of using DEA to identify high performing hospitals that might be otherwise overlooked using traditional, single-criteria methods.
Literature review

Hospitals and quality
Healthcare management faces multiple challenges to both cut costs (Smith et al., 1981; Kumar and Motwani, 1999; Watcharasriroj and Tang, 2004; Collins and Muthusamy, 2007) and improve, or at least maintain, the levels of quality delivered to their patients (McFadden et al., 2004; Li and Benton, 2003; Kunst and Lemmink, 2000) . The measurement of quality in the hospital setting can take on a variety of forms, including structure, process, and outcome measures (Campbell et al., 2000) . Examples of outcome measures include patient satisfaction surveys, LOS, and risk-adjusted mortality.
Examples of process measures include the use of beta-blockers to treat patients with chest pain and the average turnaround time between surgical operations in the OR. Patient satisfaction surveys are used to assess perceptions of the interactions themselves; while alternatively, more clinical measures such as LOS give some indication of the extent to which a process-based approach to quality management is in place. In this paper, we employ multiple outcome measures of hospital quality, including mortality, potentially preventable complications (PPCs) and LOS, in order to assess how these hospitals perform along different dimensions (Rogowski et al., 2004; McKay and Deily, 2005; Gowrisankaran and Town, 2003; Fuller et al., 2009; Milstein, 2009 ).
Previous DEA research: hospitals and quality
While DEA has been used extensively to measure the efficiency of healthcare organisations, a noted weakness of this literature has been the lack of adequate quality measures. In a meta-analysis DEA hospital efficiency studies, O'Neill et al. (2008) found that only six of 79 studies included quality measures. The outcomes used in these studies included "risk-adjusted in-hospital mortality" (Morey et al., 1995; O'Neill, 1998; Sahin and Ozcan, 2000) , "risk-adjusted readmissions" (DesHarnais et al., 1991) , "number of clinically active infections" (Solà and Prior, 2001) , and "complications" (DesHarnais et al., 1991) . A study by the Rand Corporation found that none of the healthcare efficiency studies they examined included or adequately controlled for variations in quality (McGlynn, 2008) . Instead quality was either omitted or assumed to be equal across all providers. Mutter et al. (2008) found that what appeared to be 'hospital inefficiency' could be explained by significant differences in their patients' illness burden, as measured by their co-morbidities, e.g., obesity, diabetes, and depression.
Beginning in the 1980s, the main obstacles to including quality in efficiency studies were the lack of a widely accepted quality measure and the reluctance of providers to release data on medical errors and health outcomes. In recent years, however, significant progress has been made in quality measurement and healthcare databases have become less expensive and widely available. This has led to a significant increase in both the number of quality measures and their technical sophistication. For example, the Center for Medicare and Medicaid Services (CMS) recently released a set of 216 PIs from which primary care providers can select a subset to report, in order to qualify for 'meaningful use'. The Health Care Reform Act of 2010 has allocated significant public funding for preventive medicine, health information technology and quality measurement, including bonus payments from Medicare, known as 'pay-for-performance'. In addition, Medicare will no longer reimburse hospitals for selected medical errors and re-admissions. The purpose of the changes is to better align payment incentives so as to reward quality and penalise its opposite.
Composite quality measures have the advantage of providing an overall summary of performance that allows comparisons across similar healthcare organisations. According to Jacobs (2005) , the set of PIs to be selected should include a broad range of performance measures, should not have large numbers of missing variables, should be continuous, and should be statistically independent. It is often the case that there is little agreement across the individual PIs. Yet including only a subset of PIs can introduce bias. DEA can provide a more objective way of deriving an overall performance measure from a set of PIs. DEA allows each unit to 'choose' the unique set of weights that maximise its efficiency score. If the unit is found to be inefficient, then a 'benchmark' unit exists whose quality performance is at least as good along every dimension.
The very first application of DEA for measuring hospital efficiency showed how this new technique offered several advantages relative to traditional ratio measures of efficiency (Sherman, 1984) . These advantages include the following: it compared each unit to 'best' rather than average performance; it could accommodate multiple inputs and outputs; it does not require information on relative prices; and it did not require the need for an arbitrary cut-off point to distinguish efficient from inefficient hospitals. PIs in healthcare are typically ratio measures, such as, RAMR, re-admission rates, complication rates, and so forth. Yet it is often not clear how to combine these various measures into an aggregate performance measure.
DEA models using quality measures have been applied to a variety of managerial contexts. In healthcare, measures include the ratio of actual to forecasted deaths (Morey et al., 1995) ; percentage of female patients undergoing a cervical smear (Salinas-Jimenez and Smith, 1996) ; readmission and complication rates; satisfaction ratings (Wagner et al., 2003) ; number of bedsore-free days in nursing homes (Kleinsorge and Karney, 1992) ; and the number of nursing home residents without a catheter (Shimshak et al., 2009 ). Outside of healthcare, DEA applications incorporating quality measures have included studies of educational quality (Olesen and Petersen, 1995; Ray and Mukherjee, 1998 ) and airport quality (Adler and Berechman, 2001 ).
Cardiology and quality metrics
There are multiple dimensions of performance regarding quality in hospitals. We choose three key metrics of quality in this note: LOS, patient deaths, and patient PPCs. While our example here is clearly not exhaustive, our intent is to demonstrate the utility of DEA in this setting, rather than to attempt to prescribe one solution or set of metrics as being 'the best'.
Traditional analysis evaluates comparable organisations focusing on only one dimension. For example, one might identify hospitals with the lowest mortality rates, fewest complications, or shortest LOS. Although such a single-variable analysis can easily identify a top performer, such an analysis can also fail to identify organisations that are 'hidden gems' -that perform relatively well across the board -but don't stand out as the best for a single measure. Instead, single variable analysis, by definition, identifies only those who excel in that dimension, independent of the larger picture. Performing well in multiple dimensions, however, may be preferable. We will next demonstrate this point using a sample of hospital data.
Data and sample
Our analysis is performed on data from 2008 in a sample of hospitals in the New York City metropolitan area (selected by county). The data were obtained from the New York Statewide Planning and Research Cooperative System (SPARCS). SPARCS is a major management tool created to assist hospitals, government agencies, and healthcare organisations with decision making in financial planning and monitoring of inpatient and ambulatory surgery services and costs in New York State (NYS). SPARCS was established in 1979 with cooperation between the healthcare industry and the government. It is a comprehensive patient database, and mandates that every hospital in the NYS report patient level detail on patient characteristics, diagnoses and treatments, services, and charges for every hospital discharge, ambulatory surgery patient, and emergency department admission monthly. All inpatient and outpatient data are reported back to hospitals annually at various levels of aggregation. SPARCS data have been used in several published research articles (Pasley et al., 1995; Hainsworth et al., 1997; Lagoe et al., 2001; de Jong et al., 2004) . We selected cardiology as the functional specialty to study because it accounts for a significant proportion of hospital revenues and patient volume. Additionally, cardiac procedures tend to be more complex than many other procedures within the hospital, and as such, many studies have shown that both hospital and cardiologist effects have a significant impact on quality outcomes. To reduce potential scale effects, we examined only hospitals that treat more than 1,000 cardiology patients a year. We then selected all DRGs related to cardiology (e.g., DRG 194: heart failure, DRG 190: acute myocardial infarction, DRG 196: cardiac arrest) and aggregated the data to the hospital level for our analysis.
We used three measures of hospital quality as inputs to our model: adjusted LOS, deaths, and number of observed PPCs. The adjusted LOS is measured as the ratio of actual patient days divided by the expected LOS. Actual LOS is the total number of beddays the hospital utilised for the patient mix it cared for in that year. In general, higher quality hospitals strive to move patients out of the hospital as quickly as possible because longer hospital stays typically carry a greater risk of acquiring hospital-borne illnesses and incur higher costs (Thomas et al., 1997; Ashby et al., 2000) . 'Deaths' is simply the number of cardiology patients who died in that year. PPCs is the number of complications that the hospital documented in that year that occurred in areas that were known to be avoidable (Fuller et al., 2009; Milstein, 2009) .
Our output measure in the DEA model is the total number of expected cardiology patient days the hospital 'should' have had, given its patient volume and mix. The expected value for a hospital is calculated using the mix and severity of diseases the hospital treats. To adjust for disease and severity of illness, we use 3M's All Patient Refined Diagnostic Related Groups (APR-DRGs). APR-DRGs group patients by the specific resources they consume. Each case has a three-digit APR-DRG code that indicates the disease, as well as a severity of illness subclass and a risk of mortality subclass. Both subclasses are broken down using the following format: 1 = minor, 2 = moderate, 3 = major, 4 = extreme. The assignment to these subclasses is based on principal and secondary diagnoses, age, sex, and interaction among diagnoses. The expected LOS for a patient with a particular disease in a hospital is a weighted average of the statewide averages of all severity classes for that particular disease. The weights are calculated as the proportion of cases in the hospital found in each severity class for that disease. In this type of analysis, it is critical that the appropriate controls are in place. These controls are discussed below.
Controls
The mix of patient severity varies from hospital to hospital. To control for variation in patient and case mix in our analysis, we calculated the mean and standard deviation of the AP-Case Mix Index (AP-CMI) for the population of NY hospitals (1.71 and .526, respectively) and selected only those hospitals in our targeted geographic area that fell within 2/3 of a standard deviation of the population mean. We further limited our sample to only those hospitals that had expected mortality rates (based on historical case-mix data) of .02. This approach was used to reduce the potential impact of extreme observations, as DEA results are highly sensitive to outliers (Johnson and McGinnis, 2008) . 
Analysis and results
Single dimension results
As discussed above, most examination of hospital quality performance utilises a single measure of performance. We begin our analysis and results discussion by showing the results one would find using only one measure at a time. Table 1 shows the values of three different quality performance measures for each of the 29 hospitals used in our analysis. The table shows the 'best' individual performance of the hospitals along each of the three performance metrics. The first measure is the ratio of actual patient days in the hospital to the number of days one would have expected the hospital to utilise (based on historical data) to serve their particular severity mix and volume of patients. Lower values indicate better performance. The best three hospitals using this metric are hospitals 16, 17, and 28. The second metric is the ratio of PPCs to the expected patient days. It measures the extent to which complications occur as a function of the expected patient volume. While not a perfect measure, it is important to note that this measure is used because expected days does capture elements of severity, for expected days increase as the severity level of the patient mix increases. As with the first measure, lower values are better. In our sample, hospitals 3, 16, and 27 are the best three performers.
Our third single-dimension metric is the ratio of deaths to expected days in our sample. Similar to the PPC measure above, this measures the quality of care in terms of a different metric, mortality, as a function of expected volume. Lower values are better, and the best three performers in our sample are hospitals 10, 21, and 26.
Taken together, the total set of 'top 3' best performers include hospitals 3, 10, 16, 17, 21, 26, 27, and 28. Note that this list includes only 8 hospitals because hospital 16 was a top performer for two of the measures. In a traditional analysis, an organisation assessing the best quality in this market, such as an insurer or other payer, might identify and reward only the organisations that were identified as standouts. For example, such an organisation might contract with only the top three in each category. We can see from this simple analysis that which hospitals are judged to be top performers depends on which measure is used. The question then arises whether there are other hospitals that are doing well but do not show up in a simple one-dimensional analysis.
DEA analysis -parameters and results
The DEA formulation presented below is also known as the CCR model after its inventors, Charnes, Cooper, and Rhodes (Charnes et al., 1978) . The CCR model has its early roots in economics and the seminal work on technical efficiency and distance functions by Farrell (1957) .
DEA works by estimating a piece-wise linear envelopment surface, known as the best-practice frontier. The basic DEA model can be formulated as follows: Suppose that there are n DMUs, each of which uses m inputs to produce s outputs. Let X ij (i = 1,..., m) be the amount of input i used by DMU j (j = 1,..., n); let Y rj (r = 1,..., s) be the amount of output r produced by DMU j (j = 1,..., n). The technical efficiency of DMU 0 is then given by .2)]. Efficient DMUs are those for which it is possible to find a set of relative prices for which the efficiency ratio is equal to one. Otherwise, the DMU's efficiency score will be less than one and it will be regarded as inefficient. The above model assumes constant returns-to-scale (CRS), which means that as inputs are increased by a given percentage, outputs tend to increase by the same proportional percentage. Increasing returns-to-scale occurs when an increase in the inputs results in a more than proportional increase in outputs. The above formulation can easily be modified to incorporate variable returns-to-scale (VRS). We used the input-oriented model, since the goal is to reduce inputs (bad outcomes), not to increase patient volume. To perform the analysis, we used Frontier Analyst software. Our aim here is to show the utility of using DEA in this setting, and that such analysis need not be performed by a software 'expert'. Therefore, we chose to use one of many programs that are simple to use and require little additional training. We set up the software to be in input minimising, CCR mode. Our inputs were three quality -related variables that hospitals generally aim to minimise: Actual LOS, Deaths, and PPCs. The output for our model was expected bed days, based on patient illness and severity. Table 2 shows these inputs and outputs. Thus, the aim of the model is to identify those hospitals that utilise the minimum number of 'negative' inputs given their particular patient volume/mix to achieve a given level of output. We ran this analysis in both weighted and unweighted modes. The unweighted mode allows the model to mathematically decide the 'best' performers, with no constraints on performance in each category. Thus, in this unweighted mode, a hospital could be listed as efficient based on its high performance in one area even if it performed extremely badly in the others. Weighted mode, on the other hand forces some minimum representation of the variables (in our case, 15%) in the scores. Thus, in this scenario, there is some, bare minimum element of each hospital's score that depends on every input. Table 3 shows the weighted and unweighted scores in our DEA model. While Table 3 includes the unweighted scores, the use of unweighted scores may not necessarily provide the best assessment of quality. In their examination of hospital quality, Thanassoulis et al. (1995) found that unweighted models provide high scores for some DMUs that have very poor quality in some areas by simply ignoring a subset of the measures. Clearly when mortality or complications are inputs to the model, one might be wary of ignoring those metrics entirely! As such, we focus our discussion and comparison below on the alternative model in which efficiency is calculated so that each input variable contributes a minimum of 15% to a DMU's total efficiency score. As we note below in our limitations section, this 15% weighting is not set in stone: we chose this value for our illustrative purposes here, but this is clearly a parameter that can be easily changed to fit the particulars of the analysis. Table 4 below shows more detailed results of this weighted model. Comparing the DEA results (both unweighted and weighted) with the single variable results from above shows some interesting differences. From our analysis above, the list of top single-measure hospitals included 3, 10, 16, 17, 21, 26, 27, and 28 . For consistency, we've included only the top 8 in the unweighted and weighted DEA models as well. Table 5 shows these three lists of top performers.
Therefore, in our weighted DEA model, hospitals 10, 16, and 17 fall off the 'best' list, while 8, 11, and 14 are added to it. Using a simple single-dimension approach would have missed these three top performers. Table 5 summarises these results. Figure 1 provides a quick summary for the ranking of the hospitals in our dataset. We note that using a multidimensional quality measurement, we are able to identify four 'top performers' in our dataset (as identified with green colour). A payer such as an HMO might prefer to include these 'top performers' in its network. In addition, ten hospitals are determined to be operating close to desirable levels with 80% to 99% efficiency scores. We also found out that 15 hospitals out of 29 are operating much below the acceptable levels. In terms of quality performance, a social decision maker such as a government agency or the individual hospital administrations might be willing to reevaluate the practices in these 'low performing' hospitals and implement corrective actions where necessary.
Moreover, this model provides guidance to individual hospitals in terms of how they compare to their benchmarks. The results show in detail how each hospital can potentially improve in each of the quality dimensions included in the study. For example, column 'Percent LOS reduction achievable' in Table 4 , provides the data on how much LOS improvement should be expected for each hospital before it is deemed as efficient. If we investigate the hospital #10, which was one of the top performers based on a 'deaths/expected days' single measure, the differences in the two approaches for ranking becomes more obvious. In Figure 2 , we can visualise the potential for improvement in hospital #10 in each respective quality dimension. It is seen that PPC has the most potential for improvement (i.e., hospital #10 performed the worst in this set of quality measures).
Discussion/conclusions
Pressures are mounting to reduce hospital costs. However, it is also critical to understand, assess, and reward quality performance. This objective is particularly important for payers, who might choose to reward higher-performing hospitals with more business or more attractive reimbursement rates. Government agencies might also use such findings to assess the utility of specific practices or behaviours to inform future policy decisions. In this paper, we aimed to show the utility of DEA in identifying high-performing hospitals that might otherwise not be brought to light using traditional, singledimension methods. In our example above, we present a simple DEA model using multiple quality metrics as inputs and expected patient days as the single output. Our input-minimising DEA model was able to identify and quantify the quality performance of hospitals on multiple dimensions simultaneously. This proposed method creates a more insightful and robust means of capturing a hospital's overall quality performance. It is useful for hospital administrators who are comparing hospital quality performance to consider using DEA in such a way to give better insight for benchmarking purposes. It also would be useful for payers, such as HMOs that would like to identify and reward the best performing organisations in a particular service area. This method is straightforward, simple to implement, and provides a more complete view of a hospital's quality performance.
In addition to the managerial applications of the approach described in this paper, there are implications for researchers as well. Using DEA to assess quality would provide researchers with a means to calculate an overall measure of quality that might be used to test relationships between managerial or organisational variables and quality performance in hospitals. One such direction for future research would be to use a multidimensional quality measure to replicate prior research that used a single-dimension quality measure. For example, one stream of research has considered how nurse staffing policies are related to various outcomes, such as RAMR, adverse events, job dissatisfaction, and job burnout (Aiken et al., 2003; Cho et al., 2003) . However, these studies examined each of the outcome variables separately. Future research might consider nurse staffing policies and quality, but with a multidimensional measure of quality developed using the method described in this paper. Such a study might provide a better picture of the overall impact of nurse staffing policies on hospital quality.
There are some limitations in this study that we must acknowledge. The models presented here were developed to show the utility of the approach and to show how the method may be used. For illustrative purposes, we chose three measures to demonstrate the method. They were not meant to be exhaustive. However, specific measures could easily be added or removed that make sense for a particular organisation. The data used in this study are all readily available, and there are additional metrics that are available as well. Again, it is also important to note that we chose a specific value of 15% for the weights in our model for illustrative purposes, but this value could be altered based on the specific needs of the situation.
